Objective:

To discuss the evolution from clinician to innovator in ophthalmology and introduce new technologies for glaucoma treatment.

Approach:

Key Findings:

• AlloFlo enables enhancement of uveoscleral outflow using biologic stenting.
• AlloSpan allows for circumferential canaloplasty with bioreinforcement.
• miDOC provides real-time measurement of outflow capacity during surgery.

Interpretation:

These innovations aim to improve surgical outcomes in glaucoma by providing tailored interventions based on precise measurements.

Limitations:

• Technological adoption may vary among practitioners.
• Further clinical validation may be required for new technologies.

Conclusion:

The advancements in glaucoma treatment represent a significant step towards personalized and effective surgical interventions.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.